PNC Financial Services Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.49M Buy
38,198
+1,457
+4% +$283K ﹤0.01% 618
2025
Q4
$6.38M Sell
36,741
-106
-0.3% -$19.3K ﹤0.01% 646
2025
Q3
$7.02M Sell
36,847
-4,265
-10% -$757K ﹤0.01% 621
2025
Q2
$7.38M Buy
41,112
+3,399
+9% +$590K ﹤0.01% 594
2025
Q1
$6.38M Sell
37,713
-209
-0.6% -$34.3K ﹤0.01% 602
2024
Q4
$5.72M Buy
37,922
+1,481
+4% +$230K ﹤0.01% 630
2024
Q3
$5.66M Buy
36,441
+1,509
+4% +$225K ﹤0.01% 630
2024
Q2
$4.78M Sell
34,932
-1,967
-5% -$269K ﹤0.01% 659
2024
Q1
$4.91M Sell
36,899
-8,812
-19% -$1.14M ﹤0.01% 662
2023
Q4
$6.3M Buy
45,711
+3,049
+7% +$401K 0.01% 587
2023
Q3
$5.2M Sell
42,662
-2,877
-6% -$383K ﹤0.01% 616
2023
Q2
$6.4M Sell
45,539
-2,282
-5% -$315K 0.01% 581
2023
Q1
$6.77M Sell
47,821
-155
-0.3% -$22.2K 0.01% 569
2022
Q4
$7.51M Sell
47,976
-2,462
-5% -$354K 0.01% 540
2022
Q3
$6.19M Sell
50,438
-1,381
-3% -$182K 0.01% 563
2022
Q2
$6.89M Sell
51,819
-4,646
-8% -$633K 0.01% 562
2022
Q1
$7.73M Sell
56,465
-946
-2% -$132K 0.01% 574
2021
Q4
$9.93M Sell
57,411
-4,058
-7% -$617K 0.01% 534
2021
Q3
$8.93M Sell
61,469
-546
-0.9% -$79.9K 0.01% 525
2021
Q2
$8.18M Sell
62,015
-1,326
-2% -$174K 0.01% 547
2021
Q1
$8.13M Sell
63,341
-7,623
-11% -$939K 0.01% 535
2020
Q4
$8.46M Sell
70,964
-7,599
-10% -$926K 0.01% 512
2020
Q3
$8.99M Sell
78,563
-21,158
-21% -$2.5M 0.01% 481
2020
Q2
$11.4M Sell
99,721
-407,170
-80% -$43.2M 0.02% 423
2020
Q1
$40.7M Sell
506,891
-4,525
-0.9% -$468K 0.05% 235
2019
Q4
$54.6M Sell
511,416
-16,066
-3% -$1.68M 0.05% 228
2019
Q3
$56.5M Sell
527,482
-34,827
-6% -$3.58M 0.06% 226
2019
Q2
$57.2M Buy
562,309
+486,868
+645% +$46.8M 0.06% 216
2019
Q1
$6.79M Sell
75,441
-2,389
-3% -$207K 0.01% 620
2018
Q4
$6.48M Buy
77,830
+12,588
+19% +$1.18M 0.01% 600
2018
Q3
$7.04M Sell
65,242
-1,067
-2% -$117K 0.01% 648
2018
Q2
$7.29M Sell
66,309
-3,231
-5% -$337K 0.01% 632
2018
Q1
$6.98M Buy
69,540
+931
+1% +$95.4K 0.01% 624
2017
Q4
$6.76M Sell
68,609
-1,642
-2% -$156K 0.01% 617
2017
Q3
$6.58M Sell
70,251
-1,501
-2% -$159K 0.01% 608
2017
Q2
$7.98M Sell
71,752
-6,249
-8% -$661K 0.01% 557
2017
Q1
$7.66M Sell
78,001
-4,978
-6% -$475K 0.01% 558
2016
Q4
$7.63M Sell
82,979
-12,713
-13% -$1.1M 0.01% 553
2016
Q3
$8.1M Sell
95,692
-4,666
-5% -$392K 0.01% 541
2016
Q2
$8.17M Sell
100,358
-3,859
-4% -$294K 0.01% 524
2016
Q1
$7.45M Buy
104,217
+34,875
+50% +$2.34M 0.01% 548
2015
Q4
$4.93M Sell
69,342
-34,534
-33% -$2.32M 0.01% 626
2015
Q3
$6.38M Buy
103,876
+3,444
+3% +$241K 0.01% 590
2015
Q2
$7.28M Buy
100,432
+4,563
+5% +$337K 0.01% 584
2015
Q1
$7.37M Buy
95,869
+18,135
+23% +$1.3M 0.01% 593
2014
Q4
$5.21M Buy
77,734
+19,640
+34% +$1.24M 0.01% 653
2014
Q3
$3.52M Buy
58,094
+7,170
+14% +$442K ﹤0.01% 739
2014
Q2
$2.99M Buy
50,924
+24,445
+92% +$1.43M ﹤0.01% 754
2014
Q1
$1.53M Sell
26,479
-2,492
-9% -$134K ﹤0.01% 930
2013
Q4
$1.55M Sell
28,971
-3,180
-10% -$189K ﹤0.01% 897
2013
Q3
$1.99M Sell
32,151
-1,457
-4% -$87.2K ﹤0.01% 809
2013
Q2
$2.04M Buy
+33,608
New +$2M ﹤0.01% 782

Other funds holding DGX

PNC Financial Services Group's DGX Position: Q1 2026 in Review

PNC Financial Services Group increased its Quest Diagnostics (DGX) stake by 4% in Q1 2026, buying an estimated $283K and bringing the position to 38,198 shares worth $7.49M. The position accounts for ﹤0.01% of the portfolio, ranked #618.

PNC Financial Services Group first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.2M in Q2 2019. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • PNC Financial Services Group held 38,198 shares of Quest Diagnostics worth $7.49M as of Q1 2026.
  • PNC Financial Services Group bought 1,457 Quest Diagnostics shares in Q1 2026, an estimated $283K.
  • Quest Diagnostics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #618 holding.
  • PNC Financial Services Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Quest Diagnostics position peaked at $57.2M in Q2 2019.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.